-
Post date
April 27, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelics companies, best psychedelics stocks 2021, FH.NE, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, filament health ipo, Filament Health Natural Psychedelic, Filament Health Trials, filament stock, invest in psychedelics, mental health, mental health psychedelics, Mushrooms, Psilo Scientific, psilocybin, psychedelic assisted therapy, Psychedelics
-
Post date
April 1, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, best psychedelic stock, best psychedelic stocks, best psychedelic treatment, best psychedelics companies, best psychedelics stocks, best psychedelics stocks 2021, canadian psychedelic company, clinical psychedelics, clinical trials psychedelics stocks, FH.NE, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, filament health ipo, Filament Health Natural Psychedelic, filament health neo, Filament Health Trials, filament stock, invest in psychedelics 2022, mental health psychedelics, Mushrooms, Natural Psychedelic, natural psychedelic extraction, natural psychedelics, neo exchange filament, psilo health filament, Psilo Scientific, Psychedelics
-
Post date
March 23, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, best psychedelics companies, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, Filament Health Natural Psychedelic, invest in psychedelics, mushroom, Mushrooms, Patent, Patent Application, psilocybin, psychedelic formulations, psychedelic market, Psychedelics
-
Post date
March 23, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, best psychedelics companies, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, Filament Health Natural Psychedelic, invest in psychedelics, mushroom, Mushrooms, Patent, Patent Application, psilocybin, psychedelic formulations, psychedelic market, Psychedelics
-
Post date
March 18, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelics companies, best psychedelics stocks, Canadian psychedelics companies, Canadian psychedelics market, clinical trials psychedelics, Dealer's License, Health Canada approval, licensed dealer, medical psychedelics, mushroom, mushroom formulation, mushroom laws, mushroom legalization, mushroom market, mushroom markets, mushroom research, mushroom stocks, Mushrooms, natural psychedelics, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin mushrooms, Psychedelics, psychedelics stocks 2022
